Dr. Harry A. Scholtz IV, DO

  • Salem, OR
  • Infectious disease specialist
NPI1124318639PAC ID3779709456
Medicare services, 2024
73,301
Medicare patients, 2024
247
Part D claims, 2024
65
Publications
1
MIPS score, 2024
100
Practice address
875 Oak Street SE, Suite C3095, Salem, OR 97301
Practice phone
Call (503) 561-8170
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Salem Endoscopy Center

Surgery Center - Medicare-Certified · Salem, Oregon

See all 7 affiliations

Find Dr. Scholtz's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Harry A. Scholtz IV is an infectious disease specialist in Salem, Oregon

Dr. Scholtz practices at Salem Endoscopy Center in Salem, Oregon.

Dr. Scholtz's NPI, 1124318639, was assigned on April 18, 2011. Dr. Scholtz holds Oregon license DO182681.

NPI and contact details
Medicare PAC ID
3779709456
NPI enumeration date
April 18, 2011
NPI status
Active
Accepts Medicare assignment
Yes
Practice phone
(503) 561-8170
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Estimated age
41
Medical school graduation
2011

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Harry A. Scholtz IV practices at Salem Endoscopy Center in Salem, Oregon

Dr. Scholtz's primary practice is Salem Endoscopy Center, at 875 Oak Street SE, Suite C3095, Salem, OR 97301. The practice phone is (503) 561-8170.

  • Salem Endoscopy Center
    875 Oak Street SE, Suite C3095, Salem, OR 97301Phone(503) 561-8170

Source: Dmand AI Affiliation Data

Dr. Harry A. Scholtz IV is affiliated with 3 sites of care and 4 medical groups

Dr. Scholtz's primary practice is Salem Endoscopy Center in Salem, Oregon. Dr. Scholtz is also affiliated with Salem Hospital. The medical group on file is Oregon Oncology Specialists. Dmand AI also links Dr. Scholtz to 3 more medical groups and 1 group practice or clinic, each named with a free account.

See all 7 affiliations for Dr. Scholtz

Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data

Dmand AI tracks the EHR system at Dr. Harry A. Scholtz IV's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Scholtz practices, 3 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Salem Endoscopy CenterAvailable with a free account
+2 more sites and 3 medical groupsAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every site where Dr. Scholtz practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Harry A. Scholtz IV is one of 101 infectious disease specialists in Oregon

Infectious disease is Dr. Scholtz's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dmand AI has Dr. Scholtz's licenses on file in 2 states: Oregon and Wisconsin.

Specialties and state licenses

  • Infectious disease, OregonPrimaryLicense DO182681 · taxonomy 207RI0200X
  • Internal medicine, WisconsinLicense 63891-021 · taxonomy 207R00000X

Infectious disease specialists near Dr. Scholtz

Counts of infectious disease specialists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Harry A. Scholtz IV billed Medicare for 73,301 services in 2024

CMS data shows 73,301 Medicare services from Dr. Scholtz across 16 procedure codes in 2024, for 247 Medicare patients. Medicare paid $61,692 for them.

Medicare services, 202473,301
Medicare patients247
Paid by Medicare$61,692
Procedure codes16

Dr. Scholtz's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Drugs given in the office
2023: 93,0942024: 72,37322%
Tests and treatments
2023: 5652024: 5149%
Office and hospital visits
2023: 2732024: 24710%
Lab and pathology
2023: 02024: 140
Surgery
2023: 222024: 2723%

Where Dr. Scholtz's Medicare services took place, 2024

  • In an office73,054100%
  • In a facility2470%

Dr. Scholtz compared with the Oregon median for infectious disease specialists, 2024

  • Dr. Scholtz
  • Oregon median
Medicare services
73,301vs 155472.9 times
Medicare patients
247vs 902.7 times
Part D claims
13vs 11989% below

Medians across 103 infectious disease specialists in Oregon with Dmand AI profiles that report each measure.

Dr. Scholtz's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Scholtz

Need commercial claims for Dr. Scholtz?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Scholtz and other infectious disease specialists in Oregon.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Harry A. Scholtz IV treated 247 Medicare patients in 2024, average age 72

CMS counts 247 Medicare patients who saw Dr. Scholtz in 2024. The largest group is 65 to 74, with 104 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 33% are also on Medicaid. Their average risk score is 2.73, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Scholtz's median patient age at 67, with 46% women.

Medicare patients, 2024247
Average age72
Average risk score2.73
Also on Medicaid33%

Dr. Scholtz's Medicare patients by age, 2024

Dr. Scholtz's Medicare patients by sex, 2024

  • Women10643%
  • Men14157%

Chronic conditions among Dr. Scholtz's Medicare patients, 2024

  1. High blood pressure75%
  2. High cholesterol75%
  3. Diabetes55%
  4. Arthritis50%
  5. Chronic kidney disease49%
  6. Mood disorders43%
  7. Depression39%
  8. Heart failure39%

Share of Medicare patients with each condition. A patient can have several.

Dr. Scholtz's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 67

Patient panel by sex, all payers

  • Women46%
  • Men53%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. Harry A. Scholtz IV wrote 65 Medicare Part D claims in 2024

In 2024, Dr. Scholtz wrote 65 Medicare Part D claims for 29 patients. 94% of them were for generic drugs. CMS names the drug for 13 of them, across 1 drug with 11 or more claims each, at $161 in total drug cost. In 2023, CMS named 236 claims across 10 drugs.

Part D claims, 202465
Drugs named by CMS1
Total drug cost$161
Part D patients29

Dr. Scholtz's Part D claims by kind of drug, 2024

  • Generic61 claims94%
  • Brand-name and other4 claims6%

Dr. Scholtz's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Drug classes CMS tracks in Dr. Scholtz's Part D claims, 2024

  • Antibiotics77%50 of 65 claims

Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 2362024: 1394%

Drugs named by CMS: 1 in 2024, 10 in 2023.

See all prescribing by Dr. Scholtz

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Dr. Harry A. Scholtz IV scored 100 out of 100 in Medicare's MIPS program for 2024

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Scholtz for performance year 2024, reported as part of a group. Dr. Scholtz accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Accepts Medicare assignment
Yes

Dr. Scholtz's MIPS scores, performance year 2024

  • 100of 100Final score
  • 100of 100Promoting Interoperability
  • 40of 100Improvement Activities

Each score is out of 100. The final score weighs the categories CMS scored for this clinician.

Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026

For MedTech and pharma teams

Find infectious disease specialists like Dr. Scholtz by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Harry A. Scholtz IV has 1 publication on record

Dmand AI links 1 paper to Dr. Scholtz in 2016. Dr. Scholtz's most frequent co-authors are Jackson Ssentalo Musuuza, MD, Nasia Safdar, MD and Daniel K. Shirley, MD.

Papers1

Dr. Scholtz's most frequent co-authors

Recent publications by Dr. Scholtz

See all 1 publications and co-authors

See who Dr. Scholtz researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Scholtz works with, so you can find a warm path to the right infectious disease specialists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Harry A. Scholtz IV received $421 in industry payments from 2017 to 2025

CMS Open Payments shows 13 general payments to Dr. Scholtz from 7 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 76% of the total. Abbvie Inc. paid the most, $172.

General payments to Dr. Scholtz by program year, 2017 to 2025

General payments to Dr. Scholtz by kind, 2017 to 2025

$421in total
  • Food and beverage$32276%
  • Education$9924%

Companies that paid Dr. Scholtz the most, 2017 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. Scholtz

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Sources for Dr. Harry A. Scholtz IV's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneDmand AI Affiliation Data
Primary practice, affiliations and health systemDmand AI Affiliation DataDmand AI Org Hierarchy Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Industry paymentsOpen Payments (CMS) (opens in a new tab)
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Harry A. Scholtz IV

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Harry A. Scholtz IV's NPI number?

Dr. Harry A. Scholtz IV's NPI number is 1124318639. It was assigned on April 18, 2011, and it is active in the NPI Registry.

What kind of doctor is Dr. Harry A. Scholtz IV?

Dr. Harry A. Scholtz IV is an infectious disease specialist in Salem, Oregon. The primary specialty in the NPI Registry is Infectious Disease Physician (taxonomy code 207RI0200X).

Where does Dr. Harry A. Scholtz IV practice?

Dr. Scholtz practices at 875 Oak Street SE, Suite C3095, Salem, OR 97301. Dr. Scholtz's primary practice is Salem Endoscopy Center in Salem, Oregon. Dmand AI also links Dr. Scholtz to 3 medical groups and 1 group practice or clinic.

What is Dr. Harry A. Scholtz IV's office phone number?

The practice phone on file for Dr. Scholtz is (503) 561-8170.

What is Dr. Harry A. Scholtz IV's medical license number?

Dr. Scholtz holds Oregon license DO182681, one of the licenses on file in 2 states.

Which states has Dr. Harry A. Scholtz IV been licensed in?

Dmand AI has state licenses on file for Dr. Scholtz in Oregon and Wisconsin.

Which hospitals is Dr. Harry A. Scholtz IV affiliated with?

Dr. Scholtz is affiliated with Salem Hospital.

What medical group is Dr. Harry A. Scholtz IV part of?

Dr. Scholtz is linked to Oregon Oncology Specialists. Dmand AI links Dr. Scholtz to 3 more medical groups.

Does Dr. Harry A. Scholtz IV accept Medicare?

Yes. CMS data shows Dr. Scholtz billed Medicare for 73,301 services in 2024, and Dr. Scholtz accepts Medicare assignment.

What is Dr. Harry A. Scholtz IV's MIPS score?

Dr. Scholtz's MIPS final score for performance year 2024 is 100 out of 100, reported as part of a group.

Show 7 more questionsShow fewer questions

How many Medicare patients does Dr. Harry A. Scholtz IV see?

CMS counts 247 Medicare patients who saw Dr. Scholtz in 2024, with an average age of 72.

What services does Dr. Harry A. Scholtz IV bill to Medicare?

In 2024, Dr. Scholtz's most billed Medicare services were injected or infused drug (J0878), injected or infused drug (J0696) and infusion or chemotherapy administration (96365).

What drugs does Dr. Harry A. Scholtz IV prescribe most?

In 2024 Medicare Part D data, Dr. Scholtz's most prescribed drugs by claims were Sulfamethoxazole-Trimethoprim.

Has Dr. Harry A. Scholtz IV received payments from drug or device companies?

CMS Open Payments shows $421 in general payments to Dr. Scholtz from 7 companies from 2017 to 2025. The largest total came from Abbvie Inc.

How long has Dr. Harry A. Scholtz IV been practicing?

Dr. Scholtz graduated from medical school in 2011, 15 years ago.

Does Dr. Harry A. Scholtz IV do research?

Dmand AI links 1 publication to Dr. Scholtz.

Who does Dr. Harry A. Scholtz IV publish with?

Dr. Scholtz's most frequent co-authors are Jackson Ssentalo Musuuza, MD (1 shared paper), Nasia Safdar, MD (1 shared paper) and Daniel K. Shirley, MD (1 shared paper).

Selling to infectious disease practices?

See infectious disease specialists in Oregon by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)